Your session is about to expire
← Back to Search
Diet and Lifestyle Intervention for Childhood Obesity
N/A
Waitlist Available
Led By Linda V Van Horn, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12-months, 18-months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a diet and lifestyle intervention can improve cardiovascular health metrics in children.
Who is the study for?
The KIDFIT trial is for preschool-age children (3-5 years old) with overweight or obese mothers who have a BMI of 25-40 kg/m2. The mother-child pairs must be willing to participate in the study activities, including diet and lifestyle changes, and attend study visits. They cannot join if they plan to move soon or if the child has a condition that prevents following the diet and activity guidelines.
What is being tested?
KIDFIT is testing two interventions: KIDFIT HEALTHY and KIDFIT SAFE, focusing on improving children's body fat percentage, BMI percentiles, diet quality based on DASH scores, physical activity levels, blood pressure, blood lipids without affecting their height negatively over a 12-month period.
What are the potential side effects?
There are no specific side effects mentioned for this intervention as it involves general lifestyle improvements such as better dieting practices and increased physical activity. However, all health interventions should be monitored for individual responses.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12-months, 18-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12-months, 18-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Body fat percent
Secondary study objectives
Body Mass Index (BMI) percentile
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: KIDFIT HEALTHYExperimental Treatment1 Intervention
The KIDFIT intervention group combines traditional in-person and electronic participant contacts, including two scheduled individual visits with a nutrition coach, coaching calls throughout the year, and monthly group videoconferencing-type sessions. KIDFIT Healthy participants will attend both baseline and 12 month clinical visits.
Group II: KIDFIT SAFEActive Control1 Intervention
The Control Group will be provided 12 web-based monthly Homestyles Safe Guides about safe home environments for raising children and related material emailed monthly to the moms. KIDFIT Safe web site targets environmentally safe childcare related topics such as use of sun screen, avoidance of choking hazards, pet safety, protection from electrical appliances, etc. KIDFIT Safe participants will attend both baseline and 12 month clinical visits.
Find a Location
Who is running the clinical trial?
American Heart AssociationOTHER
346 Previous Clinical Trials
4,971,120 Total Patients Enrolled
27 Trials studying Obesity
2,968 Patients Enrolled for Obesity
Northwestern UniversityLead Sponsor
1,650 Previous Clinical Trials
958,748 Total Patients Enrolled
34 Trials studying Obesity
11,462 Patients Enrolled for Obesity
Linda V Van Horn, PhDPrincipal InvestigatorNorthwestern University
1 Previous Clinical Trials
281 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: KIDFIT SAFE
- Group 2: KIDFIT HEALTHY
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.